LOS ANGELES, Aug. 21, 2009 (GLOBE NEWSWIRE) -- Universal Detection Technology (www.udetection.com) (OTCBB:UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has signed a participation agreement with the U.S. Department of Commerce (DOC) for sales assistance in the United Kingdom.
The DOC will provide an International Partner Search for UNDT. As part of the agreement, the DOC will provide the Company with information on pre-screened potential agents, distributors and partners to help explore market potential and begin to establish relationships in the United Kingdom.
"Our participation with the international partner search will give us the opportunity to market our products in the U.K. through well-established firms in the security business," said Jacques Tizabi, CEO of Universal Detection Technology. "The U.K. is a very lucrative market in the industry as well as one of the first customers of our anthrax detection system."
For more information please visit www.udetection.com or
Email us at info@udetection.com
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.
The Universal Detection Technology logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4911
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.